In this review
Language access is the reason to look closer
Mojoon advertises Chinese-English service and remote coordination of consultation, prescription and delivery. That can be useful when a reader wants to discuss care in Chinese. It should also extend to the actual prescriber’s instructions and follow-up, not only the storefront. [1]
The terms distinguish the technology platform from the medical practice and limit services by state. T2D’s conflicting descriptions of who prescribes illustrate why it helps to confirm whether you need an outside clinician. With Mojoon, check who handles each step and whether the service is available in your state. [2]
The minimum price is not the next refill budget
The semaglutide/B12 injection page lists $350–$520 per treatment and says price changes with dose. Tirzepatide/B12 is $390–$490 per session, with monthly courses and follow-up described. The cost planner can estimate the full course once you have a quote. Ask the clinic for both the per-session price and the number of sessions. [5] [6]
Confirm the actual quantity, pharmacy and any additional testing or service charge. The $400 sublingual semaglutide offer is a different product, not a fixed-price substitute for every injectable purchase. A crossed-out comparison price does not establish savings on the treatment you will receive. [7]
The refill conversation is part of the service
The injectable inclusion panels require a follow-up questionnaire before the next prescription. That is a useful distinction from assuming the next shipment happens without clinical review. Know when the request is due, who reviews it and how a problem reaches the prescriber. [5] [6]
The same panels contain contradictory frequency wording, and the oral page mixes dose units. Have the prescriber and pharmacy supply coherent written instructions for the actual product. Do not use an advertising page to reconstruct a schedule.
Choose the preparation before the convenience claim
Mojoon distinguishes injection mixtures from sublingual drops, but the oral page also uses broad FDA-approval language. The described compounded suspension should not be treated as an approved finished pill simply because the ingredient name is familiar. [5] [6] [7]
FDA does not review compounded medicines for safety, effectiveness and quality before marketing. Its GLP-1 guidance ties compounding to a medical need an approved medicine cannot meet. Language access and a convenient route are service considerations, not reasons to skip that clinical decision. [4] [8]
A result headline cannot choose the right program
The injectable pages use large weight-loss figures and branded-drug trial descriptions alongside the compound offers. They do not establish a controlled personal forecast for the selected mixture. A pharmacy badge also does not guarantee a particular batch or treatment outcome. [5] [6]
Choose care that addresses the actual difficulty, with a plan for follow-up and nutrition support when needed. Medication is not the automatic next step because a week has been difficult or a weight plateau feels frustrating.
Cancellation should happen before the package is sent
The refund policy says a subscription can be canceled and refunded if medication has not shipped; shipped prescriptions cannot be returned. Potential mistakes are referred to support for investigation. That makes the shipping event important, not a promise that medicine can be tried and sent back. [3]
The current terms refer to older payment rules without setting them out completely. Obtain the actual cancellation route, next charge and fee schedule before agreeing. Do not rely on a last-day decision when the public pages do not settle a notice window. [2]
Choose after the care and payment terms are clear
Mochi offers another remote-care comparison with separate membership and medication bills. MEDVi has a different introductory, refill and refund structure. Put the selected supply and useful clinical contact on the same basis before interpreting one small headline as better value.
Mojoon can be relevant when bilingual coordination solves a real access problem. I would wait for a named care relationship, coherent prescription instructions and an affordable continuing quote. The program should work on those terms without needing a promise of effortless or permanent weight loss.
Understanding the cost
Semaglutide injection $350–$520 per treatment with monthly courses and dose-related adjustments; tirzepatide $390–$490 per session with monthly treatment described. Sublingual drops list $400. None is adopted as a complete universal recurring total; confirm usable supply, required services, pharmacy and the next charge. [5] [6] [7]
Build your cost estimateSources
- Mojoon: current Chinese-language homepage and bilingual-service description
- Mojoon: January 1, 2026 terms, state access, separate care and incomplete remaining-terms reference
- Mojoon: April 1, 2023 refund policy, cancellation before shipping and no prescription returns
- FDA: compounded medicines and premarket review
- Mojoon: compounded semaglutide/B12, dose-dependent price and actual opened follow-up details
- Mojoon: compounded tirzepatide/B12, price range and actual opened follow-up details
- Mojoon: sublingual semaglutide drops and actual opened inclusion panel
- FDA: October 1, 2026 concerns with unapproved GLP-1 medicines
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.